Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chronic myelogenous leukemia

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Zoi K, Cross NC. Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. Int J Hematol. 2015;101:229–42.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Genovese G, Kähler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–98.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. 4.

    Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20:1472–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. 5.

    Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia. Lancet. 2007;370:342–50.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, et al. Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med. 2017;376:917–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. 7.

    Schmidt M, Rinke J, Schafer V, Schnittger S, Kohlmann A, Obstfelder E, et al. Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia. 2014;28:2292–9.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Schäfer V, Ernst J, Rinke J, Winkelmann N, Beck JF, Hochhaus A, et al. EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. J Cancer Res Clin Oncol. 2016;142:1641–50.

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Liang DC, Liu HC, Yang CP, Jaing TH, Hung IJ, Yeh TC, et al. Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A. Blood. 2013;121:2988–95.

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12:599–612.

    Article  PubMed  CAS  Google Scholar 

  11. 11.

    Abdel-Wahab O, Dey A. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics. Leukemia. 2013;27:10–15.

    Article  PubMed  CAS  Google Scholar 

  12. 12.

    Boultwood J, Perry J, Zaman R, Fernandez-Santamaria C, Littlewood T, Kusec R, et al. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. Leukemia. 2010;24:1139–45.

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, et al. Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia. Blood Cancer J. 2017;7:e559.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. 14.

    Balasubramani A, Larjo A, Bassein JA, Chang X, Hastie RB, Togher SM, et al. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. Nat Commun. 2015;6:7307.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. 15.

    Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S, et al. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood. 2014;123:541–53.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

The excellent technical assistance of Mrs. Anja Waldau and Mrs. Susan Wittig is gratefully acknowledged. The study was supported by the Deutsche José Carreras Leukämie-Stiftung e.V. (DJCLS R 15/20).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Thomas Ernst.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ernst, T., Busch, M., Rinke, J. et al. Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia. Leukemia 32, 2046–2049 (2018). https://doi.org/10.1038/s41375-018-0157-2

Download citation

Further reading

Search

Quick links